IBEX 35
10.854,70 -17,30 (-0,16%) Euro Stoxx 50
4.921,48 +30,87 (+0,63%) Dólar/Euro
1,0765 +0,0038 (+0,36%) Petróleo Brent
82,82 -0,85 (-1,02%) Oro
2.310,10 +0,50 (+0,02%) Bitcoin EUR
59.057,11 +352,82 (+0,60%)
Elanco Animal Health Incorporated (ELAN)
Después del cierre:
Elanco Animal Health Incorporated
2500 Innovation Way
Greenfield, IN 46140
United States
877 352 6261
https://www.elanco.com
Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 9300
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Jeffrey N. Simmons | President, CEO & Director | 2,46M | N/A | 1967 |
| Mr. Todd S. Young J.D. | Executive VP & CFO | 1,11M | N/A | 1972 |
| Dr. Ramiro Martin Cabral | Executive Vice President of Elanco International | 950,74k | N/A | 1972 |
| Dr. Ellen de Brabander Ph.D. | Executive Vice President of Innovation, Regulatory & Business Development | 1,14M | N/A | 1963 |
| Mr. Timothy J. Bettington | Executive Vice President of Corporate Strategy & Market Development | 1,19M | N/A | 1974 |
| Mr. James M. Meer | Senior VP & Chief Accounting Officer | N/A | N/A | 1970 |
| Mr. Chris Keeley | Senior VP & Chief Information Officer | N/A | N/A | N/A |
| Mr. David S. Kinard | Executive Vice President of Human Resources, Corporate Communications & Administration | 722,58k | N/A | 1967 |
| Katy Grissom | Head of Investor Relations | N/A | N/A | N/A |
| Ms. Shiv O'Neill | Executive Vice President, General Counsel & Corporate Secretary | N/A | N/A | 1974 |
Descripción
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Gobierno corporativo
El ISS Governance QualityScore de Elanco Animal Health Incorporated, a día 1 de mayo de 2024, es 7. Las puntuaciones base son Auditoría: 8; Tablero: 8; Derechos de los accionistas: 7; Compensación: 5.
